# ZENBEXUS
> **NDA221075** · New Drug Application · Sponsor: BRISTOL MYERS SQUIBB · Approved 2026-08-13
## Drug
- **FDA Application Number:** NDA221075
- **Application type:** New Drug Application
- **Brand name:** ZENBEXUS
- **Generic name:** IBERDOMIDE
- **Active ingredients:** IBERDOMIDE HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BRISTOL MYERS SQUIBB
- **Manufacturer:** E.R. Squibb & Sons, L.L.C.
- **First approval:** 2026-08-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=221075)
---
*MORVS · CC0 1.0*